{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:00:40Z","timestamp":1768712440489,"version":"3.49.0"},"reference-count":30,"publisher":"Galenos Yayinevi","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["dir"],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.4274\/dir.2022.221462","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T13:47:11Z","timestamp":1673617631000},"page":"428-436","source":"Crossref","is-referenced-by-count":4,"title":["Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd\u2013Chiari syndrome"],"prefix":"10.4274","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-5428","authenticated-orcid":false,"given":"Ay\u015fe","family":"Erden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8873-3476","authenticated-orcid":false,"given":"Di\u011fdem","family":"Kuru \u00d6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5453-8621","authenticated-orcid":false,"given":"Mehmet","family":"Ad\u0131gu\u0308zel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-7612","authenticated-orcid":false,"given":"Funda Seher","family":"\u00d6zalp Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Janssen HL, Garcia-Pagan JC, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38(3):364-371. [CrossRef]","DOI":"10.1016\/S0168-8278(02)00434-8"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003;38(4):793-803. [CrossRef]","DOI":"10.1053\/jhep.2003.50415"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Plompen EPC, Darwish Murad S, Hansen BE, et al. Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: the Rotterdam study. J Hepatol. 2015;63(6):1459-1465. [CrossRef]","DOI":"10.1016\/j.jhep.2015.07.026"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Xu P, Lyu L, Sami MU, et al. Diagnostic accuracy of magnetic resonance angiography for Budd-Chiari syndrome: a meta-analysis. Exp Ther Med. 2018;16(6):4873-4878. [CrossRef]","DOI":"10.3892\/etm.2018.6764"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Li Q, Chen T, Shi N, Ye W, Yuan M, Shi Y. Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B. Abdom Radiol (NY). 2022;47(2):684-692. [CrossRef]","DOI":"10.1007\/s00261-021-03300-8"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Simonetto DA, Yang HY, Yin M, et al. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces. Hepatology. 2015;61(2):648-659. [CrossRef]","DOI":"10.1002\/hep.27387"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY). 2020;45(11):3444-3462. [CrossRef]","DOI":"10.1007\/s00261-020-02656-7"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Cazals-Hatem D, Vilgrain V, Genin P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology. 2003;37(3):510-519. [CrossRef]","DOI":"10.1053\/jhep.2003.50076"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Sakr M, Abdelhakam SM, Elsayed SA, et al. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: a single-center study. World J Gastroenterol. 2017;23(4):629-637. [CrossRef]","DOI":"10.3748\/wjg.v23.i4.629"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Noone TC, Semelka RC, Siegelman ES, et al. Budd-Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging. 2000;11(1):44-50. [CrossRef]","DOI":"10.1002\/(SICI)1522-2586(200001)11:1<44::AID-JMRI6>3.0.CO;2-O"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011;46(4):277-283. Erratum in: Invest Radiol. 2013;48(2):112. [CrossRef]","DOI":"10.1097\/RLI.0b013e318200f67d"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Yoon JH, Lee JM, Paek M, Han JK, Choi BI. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol. 2016;26(6):1775-1782. [CrossRef]","DOI":"10.1007\/s00330-015-3994-7"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Faria SC, Ganesan K, Mwangi I, et al. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009;29(6):1615-1635. [CrossRef]","DOI":"10.1148\/rg.296095512"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Ferraioli G, Barr R. Ultrasound liver elastography beyond liver fibrosis assessment. World J Gastroenterol. 2020;26(24):3413-3420. [CrossRef]","DOI":"10.3748\/wjg.v26.i24.3413"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Mukund A, Pargewar SS, Desai SN, Rajesh S, Sarin SK. Changes in liver congestion in patients with Budd-Chiari syndrome following endovascular \u0131nterventions: assessment with transient elastography. J Vasc Interv Radiol. 2017;28(5):683-687. [CrossRef]","DOI":"10.1016\/j.jvir.2016.11.091"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Wang HW, Shi HN, Cheng J, Xie F, Luo YK, Tang J. Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: a pilot study. PLoS One. 2018;13(5):e0197550. [CrossRef]","DOI":"10.1371\/journal.pone.0197550"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Srinivasa Babu A, Wells ML, Teytelboym OM, et al. Elastography in chronic liver disease: modalities, techniques, limitations, and future directions. Radiographics. 2016;36(7):1987-2006. [CrossRef]","DOI":"10.1148\/rg.2016160042"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Xu P, Lyu L, Ge H, et al. Segmental liver stiffness evaluated with magnetic resonance elastography \u0131s responsive to endovascular \u0131ntervention in patients with Budd-Chiari syndrome. Korean J Radiol. 2019;20(5):773-780. [CrossRef]","DOI":"10.3348\/kjr.2018.0767"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Xu P, Lyu L, Lu X, Hu C, Xu K. Evaluating the short-term clinical efficacy of magnetic resonance elastography in patients with Budd-Chiari syndrome. Acad Radiol. 2021;28(Suppl 1):S179-S183. [CrossRef]","DOI":"10.1016\/j.acra.2021.02.016"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Mukund A, Sarin SK. Budd-Chiari syndrome: a focussed and collaborative approach. Hepatol Int. 2018;12(6):483-486. [CrossRef]","DOI":"10.1007\/s12072-018-9900-z"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Erden A, Erden I, Yurdaydin C, Karayal\u00e7in S. Hepatic outflow obstruction: enhancement patterns of the liver on MR angiography. Eur J Radiol. 2003;48(2):203-208. [CrossRef]","DOI":"10.1016\/S0720-048X(02)00229-2"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Mancuso A. An update on management of Budd-Chiari syndrome: the issues of timing and choice of treatment. Eur J Gastroenterol Hepatol. 2015;27(3):200-203. [CrossRef]","DOI":"10.1097\/MEG.0000000000000282"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Coilly A, Potier P, Brou\u00e9 P, et al. Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2020;44(4):420-425. [CrossRef]","DOI":"10.1016\/j.clinre.2020.03.015"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Erden A, Erden I, Karayal\u00e7in S, Yurdaydin C. Budd-Chiari syndrome: evaluation with multiphase contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol. 2002;179(5):1287-1292. [CrossRef]","DOI":"10.2214\/ajr.179.5.1791287"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Nilsson H, Blomqvist L, Douglas L, et al. Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis. J Magn Reson Imaging. 2014;39(4):879-886. [CrossRef]","DOI":"10.1002\/jmri.24250"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Kamimura K, Fukukura Y, Yoneyama T, et al. Quantitative evaluation of liver function with T1 relaxation time index on gadoxetic acid-enhanced MRI: comparison with signal intensity-based indices. J Magn Reson Imaging. 2014;40(4):884-889. [CrossRef]","DOI":"10.1002\/jmri.24443"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Haimerl M, Verloh N, Zeman F, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on gadoxetic acid-enhanced 3T MRI. PLoS One. 2013;8(12):e85658. [CrossRef]","DOI":"10.1371\/journal.pone.0085658"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators in Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol. 2015;9(6):856-875. [CrossRef]","DOI":"10.1586\/17474124.2015.1024224"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Fortune B, Cardenas A. Ascites, refractory ascites and hyponatremia in cirrhosis. Gastroenterol Rep (Oxf). 2017;5(2):104-112. [CrossRef]","DOI":"10.1093\/gastro\/gox010"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30(1):84-89. [CrossRef]","DOI":"10.1002\/hep.510300125"}],"container-title":["Diagnostic and Interventional Radiology"],"original-title":[],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T08:18:26Z","timestamp":1738311506000},"score":1,"resource":{"primary":{"URL":"https:\/\/dirjournal.org\/articles\/doi\/dir.2022.221462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,5,1]]},"published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.4274\/dir.2022.221462","relation":{},"ISSN":["1305-3825","1305-3612"],"issn-type":[{"value":"1305-3825","type":"print"},{"value":"1305-3612","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}